共 264 条
- [1] Kirchhof P(2017)The future of atrial fibrillation management: integrated care and stratified therapy Lancet 390 1873-1887
- [2] Benjamin EJ(2019)Heart disease and stroke statistics-2019 update: a report from the American heart association Circulation 139 e56-e528
- [3] Muntner P(2019)2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons Circulation 140 e125-e151
- [4] Alonso A(2019)Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation Clin Cardiol 42 320-329
- [5] Bittencourt MS(2019)Risk of mortality following catheter ablation of atrial fibrillation J Am Coll Cardiol 74 2254-2264
- [6] Callaway CW(2019)Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States nationwide readmissions database 2010–14 Eur Heart J 40 3035-3043
- [7] Carson AP(2011)Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias Heart Rhythm 8 1661-1666
- [8] Chamberlain AM(2017)Factors impacting complication rates for catheter ablation of atrial fibrillation from 2003 to 2015 Europace 19 241-249
- [9] Chang AR(2014)Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: incidence, characteristics, and risk factors Heart Rhythm 11 1934-1940
- [10] Cheng S(2018)Renal function and risk of stroke and bleeding in patients undergoing catheter ablation for atrial fibrillation: comparison between uninterrupted direct oral anticoagulants and warfarin administration Heart Rhythm 15 348-354